.Price to Operating Profit (P/OP) since 2005
Difficulty: Beginner
Calculation
Amgen Inc., P/OP, long-term trends, calculation
| P/OP | = | Share price1, 2, 3 | ÷ | Operating profit per share1 | Operating profit per share1 | = | Operating income1 (in millions) |
÷ | No. shares of common stock outstanding2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2005 | = | ÷ | = | ÷ | ||||||
| Dec 31, 2006 | = | ÷ | = | ÷ | ||||||
| Dec 31, 2007 | = | ÷ | = | ÷ | ||||||
| Dec 31, 2008 | = | ÷ | = | ÷ | ||||||
| Dec 31, 2009 | = | ÷ | = | ÷ | ||||||
| Dec 31, 2010 | = | ÷ | = | ÷ | ||||||
| Dec 31, 2011 | = | ÷ | = | ÷ | ||||||
| Dec 31, 2012 | = | ÷ | = | ÷ | ||||||
| Dec 31, 2013 | = | ÷ | = | ÷ | ||||||
| Dec 31, 2014 | = | ÷ | = | ÷ | ||||||
| Dec 31, 2015 | = | ÷ | = | ÷ | ||||||
| Dec 31, 2016 | = | ÷ | = | ÷ | ||||||
| Dec 31, 2017 | = | ÷ | = | ÷ |
1 USD $
2 Data adjusted for splits and stock dividends.
3 Close price on the filing date of Amgen Inc.'s Annual Report.
Source: Based on data from Amgen Inc. Annual Reports
Comparison to Competitors
Amgen Inc., P/OP, long-term trends, comparison to competitors
| Amgen Inc. | Abbott Laboratories | AbbVie Inc. | Allergan PLC | Biogen Inc. | Celgene Corp. | Gilead Sciences Inc. | Regeneron Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2005 | ||||||||
| Dec 31, 2006 | ||||||||
| Dec 31, 2007 | ||||||||
| Dec 31, 2008 | ||||||||
| Dec 31, 2009 | ||||||||
| Dec 31, 2010 | ||||||||
| Dec 31, 2011 | ||||||||
| Dec 31, 2012 | ||||||||
| Dec 31, 2013 | ||||||||
| Dec 31, 2014 | ||||||||
| Dec 31, 2015 | ||||||||
| Dec 31, 2016 | ||||||||
| Dec 31, 2017 |
Source: Based on data from Amgen Inc. Annual Reports
